Atlas Venture Opportunity Fund I, L.P.

Insider Reports History

Location
Cambridge, MA
Signature
Atlas Venture Opportunity Fund I, L.P., By: Atlas Venture Associates Opportunity I, L.P., its general partner, By: Atlas Venture Associates Opportunity I, LLC, its general partner, By: /s/ Ommer Chohan, Chief Financial Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Atlas Venture Opportunity Fund I, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Dyne Therapeutics, Inc. 10%+ Owner Common Stock 1,458,691 $43,833,665 $30.05 01 Mar 2024 Direct
Dyne Therapeutics, Inc. 10%+ Owner Common Stock 847,388 $25,464,009 $30.05 01 Mar 2024 Indirect
Day One Biopharmaceuticals, Inc. 10%+ Owner Common Stock 793,116 $9,271,526 $11.69 01 Jul 2022 Direct

Insider Reports Filed by Atlas Venture Opportunity Fund I, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DYN Dyne Therapeutics, Inc. 01 Mar 2024 2 -$1,398,347 4 10%+ Owner 05 Mar 2024, 17:07
DAWN Day One Biopharmaceuticals, Inc. 01 Jul 2022 1 $0 4 10%+ Owner 06 Jul 2022, 16:42